These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 31788089)

  • 1. Identification of differentially expressed microRNAs and the potential of microRNA-455-3p as a novel prognostic biomarker in glioma.
    Wang W; Mu S; Zhao Q; Xue L; Wang S
    Oncol Lett; 2019 Dec; 18(6):6150-6156. PubMed ID: 31788089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circular RNA hsa_circ_0005114-miR-142-3p/miR-590-5p-adenomatous polyposis coli protein axis as a potential target for treatment of glioma.
    Wei B; Wang L; Zhao J
    Oncol Lett; 2021 Jan; 21(1):58. PubMed ID: 33281969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of prognostic markers for hepatocellular carcinoma based on miRNA expression profiles.
    Wang X; Gao J; Zhou B; Xie J; Zhou G; Chen Y
    Life Sci; 2019 Sep; 232():116596. PubMed ID: 31233760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mir-139-5p inhibits glioma cell proliferation and progression by targeting GABRA1.
    Wang L; Liu Y; Yu Z; Gong J; Deng Z; Ren N; Zhong Z; Cai H; Tang Z; Cheng H; Chen S; He Z
    J Transl Med; 2021 May; 19(1):213. PubMed ID: 34001135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiRNAs Mediate GDNF-Induced Proliferation and Migration of Glioma Cells.
    Zhang BL; Dong FL; Guo TW; Gu XH; Huang LY; Gao DS
    Cell Physiol Biochem; 2017; 44(5):1923-1938. PubMed ID: 29224008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of biomarkers and construction of a microRNA-mRNA regulatory network for ependymoma using integrated bioinformatics analysis.
    Yang B; Dai JX; Pan YB; Ma YB; Chu SH
    Oncol Lett; 2019 Dec; 18(6):6079-6089. PubMed ID: 31788082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of Serum miRNAs as Effective Diagnostic Biomarkers for Distinguishing Primary Central Nervous System Lymphoma from Glioma.
    Si PP; Zhou XH; Qu ZZ
    J Immunol Res; 2022; 2022():5052609. PubMed ID: 35497882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of microRNA expression in primary human colon adenocarcinoma cells (SW480) and their lymph node metastatic derivatives (SW620).
    Yan W; Yang W; Liu Z; Wu G
    Onco Targets Ther; 2018; 11():4701-4709. PubMed ID: 30127618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioinformatics identification of potentially involved microRNAs in Tibetan with gastric cancer based on microRNA profiling.
    Luo Y; Zhang C; Tang F; Zhao J; Shen C; Wang C; Yu P; Wang M; Li Y; Di JI; Chen R; Rili G
    Cancer Cell Int; 2015; 15():115. PubMed ID: 26692821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of non-invasive biomarkers for chronic atrophic gastritis from serum exosomal microRNAs.
    Liu H; Li PW; Yang WQ; Mi H; Pan JL; Huang YC; Hou ZK; Hou QK; Luo Q; Liu FB
    BMC Cancer; 2019 Feb; 19(1):129. PubMed ID: 30736753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA profiling reveals dysregulated microRNAs and their target gene regulatory networks in cemento-ossifying fibroma.
    Pereira TDSF; Brito JAR; Guimarães ALS; Gomes CC; de Lacerda JCT; de Castro WH; Coimbra RS; Diniz MG; Gomez RS
    J Oral Pathol Med; 2018 Jan; 47(1):78-85. PubMed ID: 29032608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma microRNAs as potential new biomarkers for early detection of early gastric cancer.
    Zhu XL; Ren LF; Wang HP; Bai ZT; Zhang L; Meng WB; Zhu KX; Ding FH; Miao L; Yan J; Wang YP; Liu YQ; Zhou WC; Li X
    World J Gastroenterol; 2019 Apr; 25(13):1580-1591. PubMed ID: 30983818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of key miRNAs in papillary thyroid carcinoma based on data mining and bioinformatics methods.
    Wang J; Wu L; Jin Y; Li S; Liu X
    Biomed Rep; 2020 Jan; 12(1):11-16. PubMed ID: 31839944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of plasma microRNA expression changes in multiple system atrophy and Parkinson's disease.
    Uwatoko H; Hama Y; Iwata IT; Shirai S; Matsushima M; Yabe I; Utsumi J; Sasaki H
    Mol Brain; 2019 May; 12(1):49. PubMed ID: 31088501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of microRNA-374a predicts poor prognosis in human glioma.
    Dong Q; Yuan G; Liu M; Xie Q; Hu J; Wang M; Liu S; Ma X; Pan Y
    Exp Ther Med; 2019 Mar; 17(3):2077-2084. PubMed ID: 30867694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating miRNA Expression Profiling and Target Prediction in Patients Receiving Dexmedetomidine.
    Yang X; Chen H; Chen Y; Birnbaum Y; Liang R; Ye Y; Qian J
    Cell Physiol Biochem; 2018; 50(2):552-568. PubMed ID: 30308506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential Expression of MicroRNAs in Leprosy Skin Lesions.
    Soares CT; Trombone APF; Fachin LRV; Rosa PS; Ghidella CC; Ramalho RF; Pinilla MG; Carvalho AF; Carrara DN; Soares FA; Belone AFF
    Front Immunol; 2017; 8():1035. PubMed ID: 28970833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of dysregulated miRNAs and their regulatory signature in glioma patients using the partial least squares method.
    Shou J; Gu S; Gu W
    Exp Ther Med; 2015 Jan; 9(1):167-171. PubMed ID: 25452796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SOX11 identified by target gene evaluation of miRNAs differentially expressed in focal and non-focal brain tissue of therapy-resistant epilepsy patients.
    Haenisch S; Zhao Y; Chhibber A; Kaiboriboon K; Do LV; Vogelgesang S; Barbaro NM; Alldredge BK; Lowenstein DH; Cascorbi I; Kroetz DL
    Neurobiol Dis; 2015 May; 77():127-40. PubMed ID: 25766675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA Expression Profiling on Paired Primary and Lymph Node Metastatic Breast Cancer Revealed Distinct microRNA Profile Associated With LNM.
    Elango R; Alsaleh KA; Vishnubalaji R; Manikandan M; Ali AM; Abd El-Aziz N; Altheyab A; Al-Rikabi A; Alfayez M; Aldahmash A; Alajez NM
    Front Oncol; 2020; 10():756. PubMed ID: 32509578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.